Related Experiment Video
Updated: Oct 26, 2025

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
The clinical effect of a bronchofiberscope in treating severe ventilator-associated pneumonia
1Department of Intensive Care Unit, Zhejiang Hospital Hangzhou 310013, Zhejiang, China.
Objective:
To analyze the clinical effect of fiberoptic bronchoscopy in treating severe ventilator-associated pneumonia (VAP).
Methods:
From September 2018 to October 2019, 100 patients with severe VAP were recruited as the study cohort and randomly divided into two groups, with 50 patients in each group. The control group underwent routine treatment, such as lavage, and the experimental group underwent fiberoptic bronchoscopy. The effectiveness rates, recovery times, and respiratory mechanics indexes of the two groups were compared.
Result:
The total effective rate of the clinical treatment in the experimental group was significantly higher than it was in the control group (P < 0.05), and the recovery time in the experimental group was significantly shorter than it was in the control group (P < 0.05). After the treatment, the experimental group was significantly better than the control group (P < 0.05). After the treatment, the IL-8, CRP, and PCT levels in the experimental group were significantly lower than they were in the control group (P < 0.05).
Conclusion:
Fiberoptic bronchoscopy can significantly improve the therapeutic effect of VAP, significantly shorten patients' recovery times, significantly improve the respiratory mechanics-related indicators, and improve the therapeutic effect, so it is worthy of promotion.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
COPD: Management Using Bronchodilators and Corticosteroids
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

